Auranofin: A unique oral chrysotherapeutic agent
- 1 February 1984
- journal article
- clinical trial
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 13 (3), 255-273
- https://doi.org/10.1016/0049-0172(84)90029-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Risk of Cancer after Herpes ZosterNew England Journal of Medicine, 1982
- Hydrogen-1 and carbon-13 nuclear magnetic resonance studies of gold (I) thiomalate (‘Myocrisin’) in aqueous solution: dependence of the solution structure on pH and ionic strengthJ. Chem. Soc., Dalton Trans., 1981
- Action of gold salts in some inflammatory and immunological modelsInflammation Research, 1980
- An EXAFS study of gold co-ordination in the anti-arthritic drugs Myocrisin and SolganolJournal of the Chemical Society, Chemical Communications, 1980
- Herpes zoster at the NIH: A 20 year experienceAmerican Journal Of Medicine, 1978
- Serum gold. II. Levels in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1973
- Kinetics of aurothiomalate in serum and synovial fluidArthritis & Rheumatism, 1972
- Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexesJournal of Medicinal Chemistry, 1972
- Gold metabolism in patients with rheumatoid arthritis treated with gold compounds—reinvestigatedArthritis & Rheumatism, 1972
- Gold Treatment in Rheumatoid ArthritisAnnals Of The Rheumatic Diseases, 1945